Clinical

Dataset Information

0

A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors


ABSTRACT: The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. The main questions it aims to answer are: 1. what is the maximum tolerated dose and recommended dose for phase 2? 2. how safe and tolerable is TOS-358 at different dose levels when taken orally once or twice per day?

DISEASE(S): Ovarian Cancer,Endometrial Cancer,Her2-negative Breast Cancer,Squamous Cell Carcinoma Of Head And Neck,Carcinoma,Cervical Cancer,Colorectal Cancer,Gastric Cancer,Non-small Cell Lung Cancer,Urothelial Carcinoma,Endometrial Neoplasms

PROVIDER: 4906 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-04-15 | GSE200818 | GEO
| PRJNA685977 | ENA
2022-04-15 | GSE200828 | GEO
| PRJNA503892 | ENA
| PRJNA777575 | ENA
| PRJNA591005 | ENA
2011-06-01 | E-GEOD-22798 | biostudies-arrayexpress
| 2736832 | ecrin-mdr-crc
2022-04-09 | GSE200282 | GEO
2022-04-04 | GSE199917 | GEO